Saskia K. Klein

Learn More
Dear Editor, All-trans retinoic acid (ATRA) has become the mainstay in the treatment of acute promyelocytic leukemia (APL) because addition of ATRA to anthracyclines has been shown to improve disease-free survival and overall survival compared to chemotherapy alone [1]. ATRA induces the differentiation of leukemic promyelocytes into mature cells via its(More)
  • 1